Skip to main content

Peer Review reports

From: Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial

Original Submission
30 Dec 2019 Submitted Original manuscript
8 Feb 2020 Reviewed Reviewer Report - Jietao Lin
19 Feb 2020 Reviewed Reviewer Report - Kate Crespi
15 Mar 2020 Author responded Author comments - Joong Bae Ahn
Resubmission - Version 2
15 Mar 2020 Submitted Manuscript version 2
18 Mar 2020 Editorially accepted
7 Apr 2020 Article published 10.1186/s13063-020-04266-6

You can find further information about peer review here.

Back to article page